{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041616","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2026-09-04T22:26:16+00:00","discovered_at":"2026-09-08T10:05:00.390624+00:00","generated_at":"2026-09-08T10:05:56.731421+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Vivos converts $2.86M debt into 11.4M shares; dilution up to 52% of prior outstanding","bullets":["Twelve exchange agreements with Streeterville Capital dated Aug 31, 2026 convert $2,861,270 of note principal into up to 11,445,080 shares at avg $0.25/share.","After exchanges, Streeterville Note balance reduced to ~$3.7M from original $8.225M (June 9, 2025).","Pre-exchange shares 22,164,313; post-settlement 33,609,393, a ~52% increase from dilution.","No cash proceeds; Section 3(a)(9) exemption; shares free-trading with tacked holding period to Jun 9, 2025.","Beneficial ownership limited to 4.9%; later exchanges require sell-down of prior shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041616","json":"https://secwatch.observer/filing/0001493152-26-041616.json","markdown":"https://secwatch.observer/filing/0001493152-26-041616.md","text":"https://secwatch.observer/filing/0001493152-26-041616.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226041616/0001493152-26-041616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226041616/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T10:05:56.731421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}